Brown, Lisle/Cummings, Inc. Zoetis Inc. Transaction History
Brown, Lisle/Cummings, Inc.
- $390 Billion
- Q3 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 1,825 shares of ZTS stock, worth $216,810. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,825
Previous 2,428
24.84%
Holding current value
$216,810
Previous $379 Million
29.48%
% of portfolio
0.07%
Previous 0.1%
Shares
11 transactions
Others Institutions Holding ZTS
# of Institutions
2,084Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...